Estrogenic and clastogenic potential of the mycotoxin alternariol in cultured mammalian cells.
The mycotoxin alternariol (AOH) is found in food and beverages infected by Alternaria alternata. Because consumption of foodstuffs contaminated with A. alternata has been implicated in an elevated incidence of esophageal carcinogenesis, we have investigated the estrogenic potential, the effect on cell proliferation, and the genotoxic effect of AOH in cultured mammalian cells. AOH replaced E2 from isolated human estrogen receptors alpha and beta and increased the level of alkaline phosphatase (ALP) mRNA and the enzymatic activity of ALP in a human endometrial adenocarcinoma cell line (Ishikawa cells). The estrogenicity of AOH was about 0.01% of that of E2. The effects in Ishikawa cells were reversed by the ER antagonist ICI 182,780. Analysis of cell proliferation by flow cytometry and microscopy of Ishikawa and Chinese hamster V79 cells revealed that AOH inhibited cell proliferation by interference with the cell cycle. The genotoxic potential was assessed by the micronucleus (MN) assay and immunochemical differentiation between MN containing whole chromosomes (kinetochore-positive) and DNA fragments (kinetochore-negative) in Ishikawa and V79 cells. AOH induced kinetochore-negative MN in both cell lines. This is the first report on the estrogenic potential, inhibition of cell proliferation and clastogenicity of AOH in Ishikawa and V79 cells in vitro.
Lehmann
L
L
University of Karlsruhe, Section of Food Chemistry and Toxicology, Institute of Applied Biosciences, Germany. leane.lehmann@chemie.uni-karlsruhe.de
Wagner
J
J
Metzler
M
M
D000230:Adenocarcinoma / Q000201:enzymology / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000096:biosynthesis*; D000528:Alternaria / Q000378:metabolism; D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D045744:Cell Line, Tumor; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D002869:Chromosome Aberrations; D006224:Cricetinae; D003412:Cricetulus; D004305:Dose-Response Relationship, Drug; D016889:Endometrial Neoplasms / Q000201:enzymology / Q000378:metabolism; D004790:Enzyme Induction; D004938:Esophageal Neoplasms / Q000139:chemically induced; D047628:Estrogen Receptor alpha / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D005434:Flow Cytometry; D005506:Food Contamination; D006801:Humans; D007783:Lactones / Q000633:toxicity*; D008297:Male; D015162:Micronucleus Tests; D009153:Mutagens / Q000633:toxicity*; D012333:RNA, Messenger / Q000378:metabolism
D002800:Cholinesterase Inhibitors; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; D007783:Lactones; D009153:Mutagens; D012333:RNA, Messenger; D000469:Alkaline Phosphatase; C005197:alternariol